|
WO2008005691A1
|
|
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
|
KR20070002091A
|
|
Dpi formulation containing sulfoalkyl ether cyclodextrin
|
|
CN1980574A
|
|
Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
|
|
WO2004024126A1
|
|
Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
|
|
US6869939B2
|
|
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
|
|
AU2002254309B2
|
|
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
|
US7034013B2
|
|
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
|
US6046177A
|
|
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
AU8059198A
|
|
Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
|
|
US5874418A
|
|
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
